Biotech Manufacturing Strategies: Quality, Scalability, and Control – Insights from Dr. Ulrich Rümenapp, Bayer AG

Biotech Manufacturing Strategies: Quality, Scalability, and Control – Insights from Dr. Ulrich Rümenapp, Bayer AG

This exclusive interview with Dr. Ulrich Rümenapp, Senior Biotech Program Lead at Bayer AG, delves into the key strategies for biotech manufacturing success.

For pharma professionals involved in biotech manufacturing, this interview offers actionable insights on balancing quality, cost, and control. Gain expert perspectives on how to leverage specialised partnerships, maintain compliance, and navigate the complexities of biotech production for future-ready manufacturing strategies.